Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0TJ7S
|
||||
Former ID |
DIB007040
|
||||
Drug Name |
PDC-41
|
||||
Synonyms |
THG-113; THG-113.31; PDC-31 (iv, premature labor); PGF2 alpha antagonist (primary dysmenorrhea/topical), PDC Biotech; Prostaglandin F2 alpha antagonist (primary dysmenorrhea/topical), PDC Biotech; PDC-31 (iv, premature labor), PDC; PGF2 alpha antagonist (injectable, premature labor/dysmenorrhea), PDC Biotech; Prostaglandin F2 alpha antagonist (injectable, premature labor/dysmenorrhea), PDC Biotech
|
||||
Indication | Dysmenorrhea [ICD9: 625.3; ICD10:N94.4-N94.6] | Phase 1 | [523270] | ||
Company |
Theratechnologies Inc
|
||||
Target and Pathway | |||||
Target(s) | Prostaglandin F2-alpha receptor | Target Info | Antagonist | [526514] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.